Luke Hakes
Investor and Non Executive Director
Octopus VenturesUnited Kingdom
31 investmentsLuke Hakes is an Investor and Non Executive Director at Octopus Ventures based in United Kingdom. Luke Hakes has backed 31 companies, including Antidoteme, Zynstra and UltraSoC Technologies. Investment focus areas include Health Care, E-commerce and Payments.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
E-commerce
Payments
Medical Testing
Video Streaming
Food Delivery
Texting Platforms
Banking
Artificial Intelligence (AI)
Information Technology (IT)
Image Recognition
Analytics
Cloud Computing
Finance
Software
Healthcare
Biotechnology
InsurTech
Video
Restaurants
Mobile Apps
Health and Hospital Services
AgTech
Legal Tech
Food and Beverage
AutoTech
FinTech
Natural Language Processing
Health IT
Insurance
Financial Services
Health Diagnostics
Farming
Internet
UK-based Startups
Digital Health
Medical
Short Message Service (SMS)
Video on Demand
mHealth
Machine Learning
Visual Recognition
Portfolio Companies (31)
| 1 | Antidoteme |
| 2 | Zynstra |
| 3 | UltraSoC Technologies |
| 4 | MetraSens |
| 5 | Seatfrog |
| 6 | Surrey NanoSystems |
| 7 | Certivox |
| 8 | Graze |
| 9 | Decoholic |
| 10 | Etherapeutics |
| 11 | UltraSoc |
| 12 | Calastone |
Showing 1–12 of 31
Page 1 of 3
Access Full Contact Information
Get Luke Hakes's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.